iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
6.66
-0.04 (-0.60%)
At close: May 09, 2025, 3:59 PM
6.67
0.08%
After-hours: May 09, 2025, 04:00 PM EDT
-0.60% (1D)
| Bid | 6 |
| Market Cap | 254.9M |
| Revenue (ttm) | 35M |
| Net Income (ttm) | -130.81M |
| EPS (ttm) | -3.05 |
| PE Ratio (ttm) | -2.18 |
| Forward PE | -1.56 |
| Analyst | Buy |
| Ask | 7.14 |
| Volume | 194,839 |
| Avg. Volume (20D) | 413,547 |
| Open | 6.70 |
| Previous Close | 6.70 |
| Day's Range | 6.59 - 6.92 |
| 52-Week Range | 4.80 - 18.75 |
| Beta | 1.39 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-27.54%
iTeos Therapeutics shares are trading lower. The c...
Unlock content with
Pro Subscription
8 months ago
+10.13%
iTeos Therapeutics shares are trading higher after the company announced the oral presentation of Phase 2 GALAXIES Lung-201 interim data at the European Society for Medical Oncology Congress 2024
